PTGX:NASDAQ
Protagonist Therapeutics Inc
$134.86
arrow_downward
-1.03%(-1.40) 1D
$134.97
arrow_upward
+0.08% (+0.11)bedtimeAfter hours
Closed: Nov 11, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTGX...
Open
$136.51
High
$136.98
Low
$132.03
Mkt. cap
8.80B
Avg. vol.
725.28K
Volume
0.00
P/E ratio
28.56
52-wk high
$160.81
52-wk low
$77.00
EPS
$4.72
Beta
1.21
Shares outstanding
65.27M
No. of employees
141
Open
$136.51
High
$136.98
Low
$132.03
Mkt. cap
8.80B
Avg. vol.
725.28K
Volume
0.00
P/E ratio
28.56
52-wk high
$160.81
52-wk low
$77.00
EPS
$4.72
Beta
1.21
Shares outstanding
65.27M
No. of employees
141
News stories
From web sources and news partners
Investing.com India
·
2 days ago
Wedbush reiterates Protagonist Therapeutics stock rating on oral focus By Investing.com
About Protagonist Therapeutics Inc
CEO-
Employees141
Founded2006
HeadquartersNewark, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteprotagonist-inc.com